Kid Cards: Teaching Kids About Medicines

NCT00127543 | Withdrawn

• 1 other identifier: 05 06-089E
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

This study is being done to see if education about medicines directed toward children will improve their knowledge. The investigators also want to know if this knowledge lasts over time. Right now there are few medication instructional cards that are appropriate for children. Most of the medication cards provide information for adults. Some studies have shown that by teaching children directly, the children may take medicine at the right time for the right reason, have fewer side effects and know more about their medicine. The purpose of this research study is to see if education about medication helps children learn more about their medicine and if this knowledge lasts.

Conditions

Hemophilia; Sickle Cell Disease; Neoplasms; Blood Coagulation Disorders

Keywords

Medication Education; Pediatric

Outcome Measures

Primary Outcomes (3)

• Develop medication cards appropriate for children

• Develop a post-test to determine the effectiveness

• Obtain data to support teaching children about medication

Secondary Outcomes (1)

• Assess the clinical implications of this research

Interventions

Medication Education for Children BEHAVIORAL

Eligibility Criteria

• Age: 7 Years - 11 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Between the ages of 7 - 11 years
• Currently receiving disease management primarily coordinated through the Hematology/Oncology section
• Receiving a medication identified as a variable for this study
• Are able to assent and have a parent/guardian who is willing to consent to study participation
• Suffer no apparent developmental difficulty that would prevent or make study participation difficult

You may not qualify if:

• Individuals who cannot read or write English
• Individuals who are known to be non-compliant with medication routine and/or adhering to follow-up visits.

Sponsors & Collaborators

• Children's Mercy Hospital Kansas City: lead

Study Sites (1)

Childrens Mercy Hospitals and Clinics

Kansas City, Missouri, 64108, United States

Location

MeSH Terms

Conditions

Hemophilia A; Anemia, Sickle Cell; Neoplasms; Blood Coagulation Disorders

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, Inherited; Hematologic Diseases; Hemic and Lymphatic Diseases; Coagulation Protein Disorders; Hemorrhagic Disorders; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Anemia, Hemolytic, Congenital; Anemia, Hemolytic; Anemia; Hemoglobinopathies

Study Officials

• Heather E Curry, RN, MSN

  Childrens Mercy Hospitals and Clinics

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 5, 2005
• First Posted: August 8, 2005
• Study Start: August 1, 2005
• Study Completion: April 1, 2006
• Last Updated: January 5, 2021

Record last verified: 2020-12

Locations

US (1)